Theriva Biologics TOVX
NYSE TOVX
$0.24 +0.01 (+4.35%)
At close: Oct 2, 2026 · 4:00 PM EDT

Theriva Biologics (TOVX) Other Accumulated Expenses (2018 - 2021)

Updated

Theriva Biologics' Other Accumulated Expenses came in at $2,000 for Q2 2021, unchanged from the prior quarter.

Analysis

Theriva Biologics (TOVX) Other Accumulated Expenses (2018 - 2021) Analysis & Trends

At the end of FY2019, Theriva Biologics' Other Accumulated Expenses was $1,000, down 91.7% from FY2018.

  • Going back by year, Other Accumulated Expenses was $12,000 in FY2018.
  • The five-year range for quarterly Other Accumulated Expenses is $1,000 (Q4 2019) to $12,000 (Q4 2018).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Theriva Biologics 11.01 Mn 11.01 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2021 2,000.00
Mar 31, 2021 2,000.00
Sep 30, 2020 1,000.00
Dec 31, 2019 1,000.00
Sep 30, 2019 6,000.00
Jun 30, 2019 8,000.00
Dec 31, 2018 12,000.00
API Access

Theriva Biologics Other Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=TOVX&period=max&api_key=YOUR_API_KEY